GSK (NYSE: GSK) board members purchase ordinary shares and ADS

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

GSK plc reported a series of open‑market share purchases by its board leaders in June 2026. Non‑Executive Chair Sir Jonathan Symonds bought 1,550 ordinary shares at £19.3524 each on the London Stock Exchange on 2026-06-19. On 2026-06-22, several Independent Non‑Executive Directors, including Elizabeth McKee Anderson, Charles Bancroft, Anne Beal, Hal Dietz, Jeannie Lee and Vishal Sikka, purchased American Depositary Shares on the New York Stock Exchange at a price of $50.6908 per ADS in individual amounts ranging from 667 to 1,855 ADS.

Key Figures

Ordinary shares purchased: 1,550 shares Ordinary share price: £19.3524 per share ADS purchased by McKee Anderson: 789 ADS +3 more

6 metrics

Ordinary shares purchased 1,550 shares Sir Jonathan Symonds at £19.3524 on 2026-06-19 (XLON)

Ordinary share price £19.3524 per share Purchase by Non-Executive Chair on 2026-06-19

ADS purchased by McKee Anderson 789 ADS At $50.6908 per ADS on 2026-06-22 (XNYS)

ADS purchased by Bancroft 1,855 ADS At $50.6908 per ADS on 2026-06-22 (XNYS)

ADS purchased by Sikka 1,266 ADS At $50.6908 per ADS on 2026-06-22 (XNYS)

ADS transaction price $50.6908 per ADS All ADS purchases on 2026-06-22 by several directors

Key Terms

PDMR, American Depositary Shares, Ordinary shares of 31 ¼ pence, LEI, +1 more

5 terms

PDMR regulatory

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS')"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Ordinary shares of 31 ¼ pence financial

"Description of the financial instrument | Ordinary shares of 31 ¼ pence each"

LEI regulatory

"b) | LEI | 5493000HZTVUYLO1D793"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

Form 6-K regulatory

"Form 6-K REPORT OF FOREIGN PRIVATE ISSUER"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 06/23/2026 - 11:05 AM Accepted by SEC EDGAR 06/23/2026 - 11:05 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sir Jonathan Symonds
b)	Position/status	Non-Executive Chair
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	Purchase of 1,550 Ordinary Shares
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£19.3524	1,550

d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-19
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Elizabeth (Liz) McKee Anderson
b)	Position/status	Independent Non-Executive Director
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Purchase of 789 ADS
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.6908	789

d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Charles Bancroft
b)	Position/status	Senior Independent Non-Executive Director
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Purchase of 1,855 ADS
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.6908	1,855

d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Dr Anne Beal
b)	Position/status	Independent Non-Executive Director
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Purchase of 745 ADS
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.6908	745

d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Dr Hal Dietz
b)	Position/status	Independent Non-Executive Director
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Purchase of 667 ADS
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.6908	667

d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Dr Jeannie Lee
b)	Position/status	Independent Non-Executive Director
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Purchase of 802 ADS
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.6908	802

d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Dr Vishal Sikka
b)	Position/status	Independent Non-Executive Director
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Purchase of 1,266 ADS
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.6908	1,266

d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

	GSK plc
	(Registrant)

Date: June 23, 2026

	By:/s/ VICTORIA WHYTE --------------------------

	Victoria Whyte
	Authorised Signatory for and on
	behalf of GSK plc

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did GSK (GSK) disclose in this Form 6-K?

GSK disclosed multiple insider share purchases by senior board members. The Non-Executive Chair bought ordinary shares in London, while several Independent Non-Executive Directors bought American Depositary Shares on the New York Stock Exchange during June 2026.

Which GSK (GSK) executives or directors bought shares in June 2026?

The filing shows purchases by Sir Jonathan Symonds, Elizabeth McKee Anderson, Charles Bancroft, Anne Beal, Hal Dietz, Jeannie Lee and Vishal Sikka. They serve as Non-Executive Chair or Independent Non-Executive Directors of GSK plc and acquired ordinary shares or ADS.

How many GSK (GSK) shares and ADS were purchased and at what prices?

Sir Jonathan Symonds purchased 1,550 ordinary shares at £19.3524 each. Various Independent Non-Executive Directors bought ADS at $50.6908 each, in amounts of 789, 1,855, 745, 667, 802 and 1,266 ADS respectively, all as single transactions.

On which exchanges did the June 2026 GSK (GSK) insider purchases occur?

The Non-Executive Chair’s 1,550 ordinary-share purchase took place on the London Stock Exchange (XLON). The American Depositary Share purchases by Independent Non-Executive Directors occurred on the New York Stock Exchange (XNYS) on 22 June 2026.

What financial instruments did GSK (GSK) insiders buy in this report?

Insiders bought ordinary shares of 31¼ pence each in GSK plc and American Depositary Shares representing GSK equity. Ordinary shares were traded in London, while the ADS, identified by ISIN US37733W2044, were traded in New York.